FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897986605> ?p ?o ?g. }

• W2897986605 abstract "Rituximab plus combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is broadly accepted as standard for the treatment of diffuse large B-cell lymphoma (DLBCL). Nevertheless, there is sparsely data concerning the management of elderly patients.We performed a retrospective study of treatment with rituximab and low-dose trofosfamide in elderly patients (≥ 75 years) with DLBCL who were not suitable for R-CHOP or R-CHOP-like regimens or who did not consent to aggressive treatment. The choice regarding the qualification for R-CHOP or R-CHOP-like regimen was left to the estimation of the treating physicians.Eleven patients with a median age of 83 years (range, 75-90 years) were included. The age-adjusted international prognostic index was low risk in one patient, low-intermediate in four patients, high-intermediate in three patients, and high risk in 3 patients. All patients were evaluable for response. Five patients (45%) achieved a complete response, three (27%) a partial response, one (9%) stable disease, and two (18%) progressive disease. The estimated 1-yr overall survival was 54.5%, and the estimated 1-yr progression-free survival 45.5%, however, three patients (27%) were alive without evidence of disease at 16-20 months from start of treatment. Main toxicity was leukopenia (36% grade III or IV), whereas grade III/IV non-hematological adverse events did not occur.Due to its potency and low toxicity, trofosfamide/rituximab might represent an alternative therapy for DLBCL of elderly patients not suitable for R-CHOP. This observation, however, should be confirmed in a larger patient population within a prospective clinical trial." @default.
• W2897986605 created "2018-10-26" @default.
• W2897986605 creator A5027538640 @default.
• W2897986605 creator A5040663053 @default.
• W2897986605 creator A5041945240 @default.
• W2897986605 creator A5061498879 @default.
• W2897986605 date "2018-10-19" @default.
• W2897986605 modified "2023-10-11" @default.
• W2897986605 title "Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience" @default.
• W2897986605 cites W1201845303 @default.
• W2897986605 cites W1813126099 @default.
• W2897986605 cites W1911120442 @default.
• W2897986605 cites W1943154097 @default.
• W2897986605 cites W1969582706 @default.
• W2897986605 cites W1970153229 @default.
• W2897986605 cites W1970938866 @default.
• W2897986605 cites W1979764787 @default.
• W2897986605 cites W1996904182 @default.
• W2897986605 cites W2001801136 @default.
• W2897986605 cites W2003822673 @default.
• W2897986605 cites W2006709900 @default.
• W2897986605 cites W2012147079 @default.
• W2897986605 cites W2018071905 @default.
• W2897986605 cites W2028311823 @default.
• W2897986605 cites W2030472249 @default.
• W2897986605 cites W2035932775 @default.
• W2897986605 cites W2054738739 @default.
• W2897986605 cites W2058015212 @default.
• W2897986605 cites W2059070026 @default.
• W2897986605 cites W2076668534 @default.
• W2897986605 cites W2085230441 @default.
• W2897986605 cites W2092136432 @default.
• W2897986605 cites W2103737663 @default.
• W2897986605 cites W2106928992 @default.
• W2897986605 cites W2120373806 @default.
• W2897986605 cites W2123306692 @default.
• W2897986605 cites W2131424155 @default.
• W2897986605 cites W2133201432 @default.
• W2897986605 cites W2140451334 @default.
• W2897986605 cites W2145770938 @default.
• W2897986605 cites W2153665789 @default.
• W2897986605 cites W2167571754 @default.
• W2897986605 cites W2248522132 @default.
• W2897986605 cites W2307303548 @default.
• W2897986605 cites W2310716991 @default.
• W2897986605 cites W2333743614 @default.
• W2897986605 cites W2424646224 @default.
• W2897986605 cites W2443532650 @default.
• W2897986605 cites W2460811036 @default.
• W2897986605 cites W2484516933 @default.
• W2897986605 cites W2487308472 @default.
• W2897986605 cites W2563063147 @default.
• W2897986605 cites W2583239211 @default.
• W2897986605 cites W2602159053 @default.
• W2897986605 cites W4205736005 @default.
• W2897986605 cites W60055175 @default.
• W2897986605 doi "https://doi.org/10.1186/s12885-018-4885-5" @default.
• W2897986605 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6195694" @default.
• W2897986605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30340554" @default.
• W2897986605 hasPublicationYear "2018" @default.
• W2897986605 type Work @default.
• W2897986605 sameAs 2897986605 @default.
• W2897986605 citedByCount "9" @default.
• W2897986605 countsByYear W28979866052018 @default.
• W2897986605 countsByYear W28979866052019 @default.
• W2897986605 countsByYear W28979866052020 @default.
• W2897986605 countsByYear W28979866052021 @default.
• W2897986605 countsByYear W28979866052022 @default.
• W2897986605 countsByYear W28979866052023 @default.
• W2897986605 crossrefType "journal-article" @default.
• W2897986605 hasAuthorship W2897986605A5027538640 @default.
• W2897986605 hasAuthorship W2897986605A5040663053 @default.
• W2897986605 hasAuthorship W2897986605A5041945240 @default.
• W2897986605 hasAuthorship W2897986605A5061498879 @default.
• W2897986605 hasBestOaLocation W28979866051 @default.
• W2897986605 hasConcept C126322002 @default.
• W2897986605 hasConcept C141071460 @default.
• W2897986605 hasConcept C143998085 @default.
• W2897986605 hasConcept C2776694085 @default.
• W2897986605 hasConcept C2776755627 @default.
• W2897986605 hasConcept C2778336483 @default.
• W2897986605 hasConcept C2778476033 @default.
• W2897986605 hasConcept C2778559949 @default.
• W2897986605 hasConcept C2778720950 @default.
• W2897986605 hasConcept C2778822529 @default.
• W2897986605 hasConcept C2779338263 @default.
• W2897986605 hasConcept C2779429289 @default.
• W2897986605 hasConcept C2779725641 @default.
• W2897986605 hasConcept C2780073493 @default.
• W2897986605 hasConcept C2780653079 @default.
• W2897986605 hasConcept C2781413609 @default.
• W2897986605 hasConcept C71924100 @default.
• W2897986605 hasConcept C90924648 @default.
• W2897986605 hasConceptScore W2897986605C126322002 @default.
• W2897986605 hasConceptScore W2897986605C141071460 @default.
• W2897986605 hasConceptScore W2897986605C143998085 @default.
• W2897986605 hasConceptScore W2897986605C2776694085 @default.
• W2897986605 hasConceptScore W2897986605C2776755627 @default.
• W2897986605 hasConceptScore W2897986605C2778336483 @default.
• W2897986605 hasConceptScore W2897986605C2778476033 @default.

• next